Retention and Re-Engagement in Treatment for Addiction follo
06/15/2021 - 05/31/2022 (PI)
National Institute on Drug Abuse/NIH/DHHS
1K23DA054363-01

1. Kimmel SD, Xuan Z, Yan S, Lambert AM, Formica SW, Green TC, Carroll JJ, Bagley SM, Rosenbloom D, Beletsky L, Walley AY. Characteristics of post-overdose outreach programs and municipal-level opioid overdose in Massachusetts. Int J Drug Policy. 2023 Sep 13; 120:104164.View Related Profiles.

   Kimmel, Simeon
   Xuan, Ziming
   

   PMID: 37713939; DOI: 10.1016/j.drugpo.2023.104164;
2. Zang X, Walley AY, Chatterjee A, Kimmel SD, Morgan JR, Murphy SM, Linas BP, Nolen S, Reilly B, Urquhart C, Schackman BR, Marshall BDL. Changes to opioid overdose deaths and community naloxone access among Black, Hispanic and White people from 2016 to 2021 with the onset of the COVID-19 pandemic: An interrupted time-series analysis in Massachusetts, USA. Addiction. 2023 Aug 28. PMID: 37640687; DOI: 10.1111/add.16324;
3. Paradise RK, Desmarais J, O'Malley SE, Hoyos-Cespedes A, Nurani A, Walley AY, Clarke J, Taylor S, Dooley D, Bazzi AR, Kimmel SD. Perspectives and recommendations of opioid overdose survivors experiencing unsheltered homelessness on housing, overdose, and substance use treatment in Boston, MA. Int J Drug Policy. 2023 Jul 29; 119:104127. PMID: 37523844; DOI: 10.1016/j.drugpo.2023.104127;
4. Kimmel SD, Wurcel AG. Hit Me With Your Best Shot: Long-Acting Therapies to Improve HIV Viral Suppression. Ann Intern Med. 2023 Jul; 176(7):1001-1002. PMID: 37399553
5. Hingorani KS, Barnes E, Carneiro T, Sader E, Anand P, Ong CJ, Chung D, Daneshmand A, Suchdev K, Takahashi C, Greer D, Shulman JG, Aparicio HJ, Nguyen TN, Romero JR, AbdalKader M, Feske SK, Kimmel SD, Weinstein ZM, Fagan M, Dobrilovic N, Awtry E, Cervantes-Arslanian AM. Strokes in Patients With Injection Drug Use and Tricuspid Valve Endocarditis - A Case Series. Neurohospitalist. 2023 Jul; 13(3):272-277.View Related Profiles.

   Daneshmand, Ali
   Cervantes-Arslanian, Anna
   Ong, Charlene
   Takahashi, Courtney
   Greer, David
   Awtry, Eric
   Aparicio, Hugo
   Romero, Jose
   Shulman, Julie
   Suchdev, Kushak
   Fagan, Maura
   Abdalkader, Mohamad
   Anand, Pria
   Kimmel, Simeon
   Feske, Steven
   Nguyen, Thanh
   Weinstein, Zoe
   

   PMID: 37441214; PMCID: PMC10334046; DOI: 10.1177/19418744231159460;
6. Xuan Z, Yan S, Formica SW, Green TC, Beletsky L, Rosenbloom D, Bagley SM, Kimmel SD, Carroll JJ, Lambert AM, Walley AY. Association of Implementation of Postoverdose Outreach Programs With Subsequent Opioid Overdose Deaths Among Massachusetts Municipalities. JAMA Psychiatry. 2023 May 01; 80(5):468-477.View Related Profiles.

   Walley, Alexander
   Rosenbloom, David
   Bagley, Sarah
   Kimmel, Simeon
   Xuan, Ziming
   

   PMID: 36920385; PMCID: PMC10018400; DOI: 10.1001/jamapsychiatry.2023.0109;
7. Jawa R, Tin Y, Nall S, Calcaterra SL, Savinkina A, Marks LR, Kimmel SD, Linas BP, Barocas JA. Estimated Clinical Outcomes and Cost-effectiveness Associated With Provision of Addiction Treatment in US Primary Care Clinics. JAMA Netw Open. 2023 Apr 03; 6(4):e237888.View Related Profiles.

   Linas, Benjamin
   Barocas, Joshua
   Kimmel, Simeon
   

   PMID: 37043198; PMCID: PMC10098970; DOI: 10.1001/jamanetworkopen.2023.7888;
8. Harvey L, Kimmel SD, Edelman EJ. Meeting the Moment: More Infectious Disease Physicians Must Be Prepared to Provide Buprenorphine. Clin Infect Dis. 2023 Apr 03; 76(7):1205-1208.View Related Profiles.

   Harvey, Leah
   Kimmel, Simeon
   

   PMID: 36695340; DOI: 10.1093/cid/ciad036;
9. Alrawashdeh M, Rhee C, Klompas M, Larochelle MR, Poland RE, Guy JS, Kimmel SD. Association of Early Opioid Withdrawal Treatment Strategy and Patient-Directed Discharge Among Hospitalized Patients with Opioid Use Disorder. J Gen Intern Med. 2023 Aug; 38(10):2289-2297.View Related Profiles.

   Larochelle, Marc
   Kimmel, Simeon
   

   PMID: 36788169; PMCID: PMC10406767; DOI: 10.1007/s11606-023-08059-w;
10. Cohen SM, Joab R, Bolles KM, Friedman S, Kimmel SD. Ending Medical Complicity With Skilled-Nursing Facility Discrimination Against People With Opioid Use Disorder. Ann Intern Med. 2023 Mar; 176(3):410-412. PMID: 36745883; DOI: 10.7326/M22-3049;

Showing 10 of 49 results. Show More

A Notorious Boston Intersection, Mass and Cass, Faces an Opioid Overdose Crisis. BU Researchers Are Turning to Survivors for Answers

A Notorious Boston Intersection, Mass and Cass, Faces an Opioid Overdose Crisis. BU Researchers Are Turning to Survivors for Answers

Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients

Long-Acting, Injected HIV Meds Can Help Tough-to-Treat Patients

---

To protect people with addiction from discrimination, the Justice Dept. turns to a long-overlooked tool: the ADA

BMC Pilots Training Program to Improve Post-Acute Care for Patients with Substance Use Disorder

Patients with Opioid Use Disorder Are Routinely Rejected from Post-Acute Care Facilities in the Northeast, Study Finds

COVID-19: Unionized Nursing Homes Showed Lower Resident Mortality Rates

Post-acute care facilities in MA disproportionately reject referred patients with opioid use disorder

Patients with opioid use disorder often rejected for skilled follow-up care, study finds

SNF opioid problems didn’t end after prosecutions began

Opioid Use Disorder Plays Significant Role in Many Sepsis Cases

Rejection of Referrals based on Substance Use Diagnosis and Treatment

Emergency Departments Have a Major Opportunity to Boost HIV Testing

Principles of Harm Reduction in Young Adults with Substance Use Disorder

A Missed Opportunity for Medication for Opioid Use Disorder (MOUD) Initiation: Infective Endocarditis Hospitalization

HIV and Overdose Care Critical as Pandemic Yields Increased Harm

Patients with opioid use disorder face discrimination in post-acute care

Report finds Massachusetts’ skilled nursing facilities and rehab centers openly discriminated against addiction patients.

Post-Acute Care Facilities Often Reject Patients With Substance Use Disorder

29% Of Mass. Nursing Homes Refused Patients Who’ve Used Opioids, Study Finds